<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en">
<head>
	<link rel="shortcut icon" type="image/x-icon" href="/favicon.ico">
	<meta http-equiv="content-type" content="text/html; charset=utf-8" />
	<meta name="description" content="We will investigate how defects in DNA damage response and repair pathways can be used for developing rational therapies in breast and ovarian cancer, in particular therapy strategies using PARP inhibitors. " />
	<meta name="keywords" content="DNA repair, breast cancer, ovarian cancer, PARP inhibitors, BRCA1, BRCA2, DNA damage response" />
	<meta name="author" content="Your Name / Original design: Andreas Viklund - http://andreasviklund.com/" />
	<link rel="stylesheet" type="text/css" href="ddresponse.css" media="screen,projection" title="DDResponse" />
	<title>DDResponse</title>
</head>

<body>
<div id="container">
		<div id="logo">
		<h1>&nbsp;</h1>

		<p>&nbsp;</p>
	</div>

	<div id="main">
		<h2 class="hide">Site menu:</h2>
		<ul id="navitab">
			<li><a class="current" href="index.html">Home</a></li>
			<li><a href="general.html">Scientific Info</a></li>
			<li><a href="#">Public Info</a></li>

		</ul>

		<div id="feature">
			<a href="http://ec.europa.eu/index_en.htm"><img src="images/euflag.jpg" class="alignleft" alt="EU flag" /></a>
			<h2>DDResponse</h2><p>DDResponse is a Collaborative Project funded by the 7th Framework Programme of the European Commission in the theme Health. The start date of the project is 1 February 2011. It will end on 31 January 2015. </p>
			<hr />
		</div>

<p>

			<center><h3><b>DDReponse - New hope for hereditary breast and ovarian cancer patients</b></h3>
			In 2011-2015, the EU-funded scientific project DDResponse tested and validated a new treatment for hereditary breast and ovarian cancer. 
			This led to the Marketing Authorization of both the EU and the US for this new treatment, giving new hope to patients with relapsed 
			hereditary ovarian cancer. Authorization for hereditary breast cancer is expected to follow soon.<BR> 
			Mark O&#146;Connor, senior scientist of AstraZeneca (UK), and Jan Hoeijmakers, professor in Genetics at Erasmus MC (NL) highlight the 
			scientific basis for the new treatment and explain why this new treatment is so effective<BR><BR> 
			<table class=gewoon>
				<TR>
				<TD class=gewoon width=300><a href="Mark OConnor-HD.mp4">
					<IMG SRC="images/Snapshot_movie_Mark_4a.gif" ALT="Snapshot 1" border=0>
					</TD>
					<TD align=right valign=bottom class=gewoon>
					<a href="Jan Hoeijmakers-HD.mp4"><IMG SRC="images/Snapshot_movie_Jan_2a.gif" ALT="Snapshot 2" border=0>
				</TD>
				</TR>

				<TR>
				<TD class=gewoon width=300 align=center><a href="Mark OConnor-HD.mp4">Mark O&#146;Connor
				</TD>
				<TD align=center valign=bottom class=gewoon>
				<a href="Jan Hoeijmakers-HD.mp4">Jan Hoeijmakers
				</TD>
				</TR>
			</TABLE> 
			
		</p>
		

<p>

			<center><h3>The project DDresponse is now visualized in the animated movie <BR>&#39;DDresponse and Breast Cancer&#39;, available with 
			English and Dutch voice-over.<BR><BR> 
			<table class=gewoon>
				<TR>
				<TD class=gewoon width=300><a href="https://www.youtube.com/watch?v=rWc7kIzvBYo">
					<IMG SRC="images/Snapshot_animatie_1.gif" ALT="Snapshot 1" border=0>
					</TD>
					<TD align=right valign=bottom class=gewoon>
					<a href="https://www.youtube.com/watch?v=6nUBxlthL4E"><IMG SRC="images/Snapshot_animatie_2.gif" ALT="Snapshot 2" border=0>
				</TD>
				</TR>

				<TR>
				<TD class=gewoon width=300 align=center><a href="https://www.youtube.com/watch?v=rWc7kIzvBYo">English
				</TD>
				<TD align=center valign=bottom class=gewoon>
				<a href="https://www.youtube.com/watch?v=6nUBxlthL4E">Dutch
				</TD>
				</TR>
			</TABLE> 
			
		</p>



<p>
<h2>Brochure 'Hope on the Horizon'</h2>
The DDResponse project aims to make significant progress towards personalized treatment and new drugs for breast 
cancer patients. In the brochure Hope on the Horizon you can read background information on breast cancer, its link 
with DNA repair and the long scientific journey towards better treatment. The brochure is available in 
<a href="Hope-on-the-Horizon_UK.pdf" target=_blank><b>English</b> </a> and <a href="Hoop-aan-de-Horizon_NED.pdf" target=_blank><b> Dutch</b></a>.
</p>
<BR>
<p>
			<center><h3>DDResponse presents itself in two short movies:<BR> <a href="http://www.youtube.com/watch?v=Mg3d7bi7T9A&feature=youtu.be"target=_blank>Understanding the DNA Damage Response</a> 
			and <a href="https://www.youtube.com/watch?v=MRKl4VJjoBg"target=_blank> Meet the Scientists</a>. <BR><BR>
<table class=gewoon><TR><TD class=gewoon width=300><a href="http://www.youtube.com/watch?v=Mg3d7bi7T9A&feature=youtu.be/"><IMG SRC="images/Snapshot_DDR_Movie1.png" ALT="Snapshot 1" border=0>
</TD><TD align=right valign=bottom class=gewoon>
<a href="https://www.youtube.com/watch?v=MRKl4VJjoBg"><IMG SRC="images/Snapshot_DDR_Movie2.png" ALT="Snapshot 2" border=0></TD></TR></TABLE> 
			
		</p>


<br>


<br>
		<h2>Welcome</h2>


<p>One of the most important developments in biomedical genetics over the last decade is the realisation that preservation of genetic integrity mediated by the DNA damage response (DDR) is both of enormous fundamental and medical importance. This holds most notably for cancer and many aging-related diseases, which have strong connections with DNA damage and genome maintenance. 
</p><p>
As these diseases represent the main causes of mortality and morbidity in many countries world-wide, this 'DDResponse' proposal directly addresses the prevailing medical needs of all modern societies. 
</p><p>
The principal objective of this collaborative project is to unlock the full potential of genome maintenance / DNA damage response (DDR) mechanisms to derive new therapies, assess individual susceptibility and predict individual responses to anti-cancer therapies that exploit DDR deficiencies, which appear universal in most, if not all, cancers. The proposal focuses on, but is not limited to, breast cancer.


</p>
<br><br><br>
		

	</div>

	<div id="sidebar">
		<h2>Menu</h2>
		<ul class="sidelink">
			<li><a href="#">>Welcome</a></li>
			<li><a href="general.html">General Introduction</a></li>
			<li><a href="strategy.html">Overall strategy and general description</a></li>
			<li><a href="organisation.html">Organisation</a></li>
			<li><a href="./participants/participants.html">Participants</a></li>
			<li><a href="./documents/documents.html">Documents</a></li>
			<li><a href="./meeting/Final-meeting.html">International symposium 2015</a></li>
			<li><a href="./restricted/restricted.html">Restricted</a></li>
		</ul>

		<h2>News</h2>
			<ul>
				<li>New <a href="http://youtu.be/Mg3d7bi7T9A"target=_blank>intro movie</a><br>on the project</a></li>

				
			</ul>
			<center><a href="http://ec.europa.eu/index_en.htm"><img src=./images/jaune.jpg></a><br><br><a href="http://cordis.europa.eu/fp7/home_en.html"><img src=./images/FP7-gen-RGB.jpg></a></center>
	</div>
</div>

<div id="footer">
	<p>Copyright &copy; 2011 DDResponse &middot;  <a href="credits.html">Credits</a></p>
</div>

<script type="text/javascript">

  var _gaq = _gaq || [];
  _gaq.push(['_setAccount', 'UA-4004928-10']);
  _gaq.push(['_trackPageview']);

  (function() {
    var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
    ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
  })();

</script>
</body>
</html>